Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'drug study'
drug study published presentations and documents on DocSlides.
Maraviroc ( Selzentry ) Prepared by:
by amelia
David H. Spach, MD. Brian R. Wood, MD. Last Update...
Breathe Pennsylvania: Tuberculosis Educational Conf
by jade
.. April. 24, 2015. Ed . Zuroweste, MD. . PA ...
Under Reporting Practices of ADR: An Observational Study
by ashley
Kondalkar Avinash, Sharma Rahul, Patle Shiker, and...
E stablished S tatus E
by bety
pilepticus . T. reatment . T. rial . (ESETT. ). A ...
Protocol and MoP Overview
by angelina
Platelet-Oriented Inhibition in New TIA . a...
Pharmaceutical Methods
by naomi
Vol 7, Issue 2, Jul-Dec, 2016 104 Design and Evalu...
sterlund T Barzi S Bernsten C
by oryan
We . Consumer views on safety of over - the - coun...
LIST OF ABBREVIATIONS
by singh
5 AE - adverse event ALT - alanine aminot...
The Appropriate Use of Activated Charcoal in
by sylvia
4407 Pharmaceutical and Toxicological Approaches A...
Research Policy on Case-control and Cohort Study Design in Pharmaceutical Care
by CutiePatootie
Yousef Ahmed . Alomi. , Amal Hassan Al-Najjar, . M...
Imp Instructions to the scholars
by WheresMyPizza
Use the template Given in the following slides i.e...
Deciding to Participate in Research
by jasmine
The Pros and Cons. Natalie Diaz, MD. Pacific Neuro...
Responsibilities of the Principal Investigator
by faith
Anne Roussell, RN. [adapted from . MAGI/. Complion...
Cerebellar ataxia research update
by ximena
Dr Julie Vallortigara. Forward with Hope . Overvie...
Framing Your Research Question
by maisie
Alison K. Hall, PhD. Associate Dean, Research Work...
Preparing for an FDA Inspection
by felicity
. Kathy Gilmartin, MSN, CRNP, CCRC. ...
Guidance on Research FollowUp
by fiona
Defining a follow-up period is important to the re...
A human absorption metabolism and excretion hAME study is conducted to
by sophia2
disposition in the body and to characterize its me...
(NYSE American: CANF) (TASE:CFBI)
by kampsta
Can - Fite Presentation September 2020 (NYSE Ameri...
Industry and CRO Perspective on Clinical Trial Quality
by karlyn-bohler
Industry and CRO Perspective on Clinical Trial Qu...
Chapter 3: Producing Data
by tawny-fly
Chapter 3: Producing Data © 2017 W.H. Freeman an...
Roy M. Gulick, MD, MPH Rochelle Belfer Professor in Medicine
by trish-goza
Weill Cornell Medicine. New York, New York. Inves...
SAFETY PRACTICES AND REPORTING IN CLINICAL RESEARCH
by min-jolicoeur
Acknowledgement. Acknowledgment to . Ms. Chun Ge...
Improving Adverse Drug Reaction Information in Product Labels
by liane-varnes
PSI Conference . May 2017 . Sally Lettis GlaxoSmi...
A Study Among Key Stakeholders and the Use of Real World Data and Evidence in Clinical Research
by jane-oiler
February 15, 2017. Clinical Innovation Seminar. M...
The practice of Regulatory
by natalia-silvester
intelligence: . case studies. OMICS 5. th. Inte...
Preparing for an FDA Inspection
by min-jolicoeur
. Kathy Gilmartin, MSN, CRN...
SO YOU THINK YOU WANT TO DO RESEARCH, HUH?
by jane-oiler
Laura Herbelin, Research Instructor. University o...
Rectal Microbicides: Where We’re Heading
by giovanna-bartolotta
Craig Hendrix, MD. Johns Hopkins University. Micr...
Consent Coercion Creep Patrick Herbison, MEd, CIP
by yoshiko-marsland
Assistant Director of Compliance. Office of Human...
Drugs and Consciousness Psychoactive Drugs: chemicals that alters one’s perceptions and mood
by ellena-manuel
Drugs and Consciousness. Continued use of psychoa...
Preparing for an FDA Inspection
by tawny-fly
. Kathy Gilmartin, MSN, CRN...
The Downside of Publication
by liane-varnes
Group 2: Jing Kai, . Nabilah. and Soon Guan. Pre...
1 Christopher Loss, DVM Division of Therapeutic Drugs for Non-Food Animals
by yoshiko-marsland
Office of New Animal Drug Evaluation. USFDA Cente...
AVOIDING BIAS AND RANDOM ERROR IN DATA ANALYSIS
by faustina-dinatale
Susan . Ellenberg. , Ph.D.. Perelman School of Me...
Roy M. Gulick, MD, MPH Rochelle Belfer Professor in Medicine
by debby-jeon
Weill Cornell Medicine. New York, New York. Inves...
Expedited Adverse Event
by pasty-toler
Reporting Requirements. Protocol References. Sect...
1 Drug.... Many Complaints!
by test
Louise . Rutherford . Paresh . Masuria . GlaxoSmi...
Comparison of Adherence among Partners’ PrEP Participants on Placebo before and after Release of
by briana-ranney
B. Wamuti. , J. Odoyo, B. Rono, C. Cohen, E. Buku...
Roadmap of stability studies for
by cheryl-pisano
Biosimilar. product development. Dr.. Rashbehar...
Load More...